ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ibrance 125 mg, Filmtabletten - 21
69183003 Pfizer AG
Ibrance 125 mg, Filmtabletten06.09.2023
  06.09.2023
(L01EF01) 
WHO-DDD05.09.2028
07.16.10.21
07.16.10. 
A  
Yes 
IP 
1973.56Yes
    
10 %2162.80
  
7680691830037Synthetika
  
Composition
palbociclibum 125 mg, cellulosum microcristallinum, silica colloidalis anhydrica, crospovidonum, magnesii stearas, acidum succinicum, hypromellosum, E 171, triacetinum, E 132, E 172 (rubrum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
 125 mg
BAG: Active AgentDose
 125 mg
 
Inactive agents additional_information
   
Succinic Acid  
   
   
  color.
  color.
  color.
Hypromellosum  
   
   
Silica Colloidalis Anhydrica  
   
 
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home